Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Colorectal Neoplasms × N-dihydrogalactochitosan × Clear all

Phase

Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 1 Melanoma 1 Colorectal Neoplasms 1

Interventions

Cetuximab 39 Irinotecan 33 pembrolizumab 32 Oxaliplatin 32 Bevacizumab 32 Capecitabine 31 Fluorouracil 30 Leucovorin 29 Nivolumab 20 Gemcitabine 13 regorafenib 12 Cyclophosphamide 12 Folfox protocol 11 Cisplatin 10 Pemetrexed 9 Carboplatin 9 tislelizumab 8 Paclitaxel 8 IFL protocol 8 Panitumumab 7 130-nm albumin-bound paclitaxel 7 durvalumab 6 Ipilimumab 6 HMPL-013 6 Drug Therapy 6 irinotecan sucrosofate 5 Trifluridine 5 Specimen Handling 5 Interleukin-2 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06630624 2025-07-03

INJECTABL-II

Amsterdam UMC, location VUmc

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡